Estradiol / Progesterone Troche

This Estradiol and Progesterone troche provides a synergistic approach to hormone replacement therapy by utilizing bioidentical estrogen to alleviate vasomotor symptoms while incorporating progesterone to ensure critical endometrial protection. The transmucosal delivery system offers a distinct clinical advantage by bypassing first-pass hepatic metabolism, which enhances bioavailability and maintains more stable systemic concentrations compared to traditional oral routes. This specialized dosage form allows for precise, individualized hormone optimization while minimizing metabolic strain on the liver, ultimately improving therapeutic outcomes for patients managing menopausal transitions.